Comparison of potassium‐titanyl‐phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non‐randomized two‐centre study
Authors:
- Robin RuszatRRRobin Ruszat
- Stephen F. WylerSWStephen F. Wyler
- Michael SeitzMSMichael Seitz
- Kurt LehmannKLKurt Lehmann
- Constanze AbeCAConstanze Abe
- Gernot BonkatGBGernot Bonkat
- Oliver ReichOROliver Reich
- Thomas C. GasserTGThomas C. Gasser
- Alexander BachmannABAlexander Bachmann
- 23 October 2008
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 102 (10) , 1432-1439
Abstract
OBJECTIVES: To evaluate the intermediate‐term clinical efficacy and the rate of complications in 80 W photoselective vaporization of the prostate (PVP) with the potassium‐titanyl‐phosphate laser (Greenlight TM , (AMS, Minnetonka, MN, USA) compared with transurethral resection of the prostate (TURP) in a prospective non‐randomised two‐centre study. PATIENTS AND METHODS: From December 2003 to August 2006, 396 patients (PVP 269, TURP 127) with lower urinary tract symptoms secondary to benign prostatic hyperplasia were included in the study. There was a significant difference in mean age (72 years for PVP vs 68 for TURP, P = 0.001). Patients were therefore stratified in age categories (80 years) and compared for perioperative variables, functional outcome and complications, with a follow‐up of up to 24 months. RESULTS: The mean prostate size was greater (overall, 62 vs 48 mL, P < 0.001) and mean operative duration longer (overall 72 vs 53 min; P = 0.001) for PVP in all age categories. The rate of intraoperative bleeding (3% vs 11%), blood transfusions (0% vs 5.5%) and capsule perforations (0.4% vs 6.3%), and early postoperative clot retention (0.4% vs 3.9%) was significantly lower for PVP. Hospitalization time was significantly shorter in the PVP group for patients aged P = 0.001). The improvement of peak urinary flow rate was higher after TURP for any age category. The International Prostate Symptom Score and postvoid residual volume during the follow‐up showed no significant difference. After 12 months the overall prostate size reduction was 63% (−30 mL) after TURP and 44% (−27 mL) after PVP. The rate of repeat TURP/PVP was higher in the PVP group (6.7% vs 3.9%, not significant) within the follow‐up of up to 2 years. The incidence of urethral and bladder neck strictures was comparable. CONCLUSIONS: PVP was more favourable in terms of perioperative safety. Although patients assigned for PVP were older and had larger prostates, PVP resulted in a similar functional outcome. Further follow‐up is needed to draw final conclusions about the long‐term efficacy of PVP.Keywords
This publication has 31 references indexed in Scilit:
- Complications and Early Postoperative Outcome After Open Prostatectomy in Patients With Benign Prostatic Enlargement: Results of a Prospective Multicenter StudyJournal of Urology, 2007
- KTP Laser versus Transurethral Resection: Early Results of a Randomized TrialJournal of Endourology, 2006
- Impact of prostate‐specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 yearsBJU International, 2006
- Holmium laser enucleation of the prostate for prostates of >125 mLBJU International, 2005
- Photoselective Vaporization (PVP) versus Transurethral Resection of the Prostate (TURP): A Prospective Bi-Centre Study of Perioperative Morbidity and Early Functional OutcomeEuropean Urology, 2005
- IMMEDIATE AND POSTOPERATIVE COMPLICATIONS OF TRANSURETHRAL PROSTATECTOMY IN THE 1990sJournal of Urology, 1999
- Is transurethral resection of the prostate still justified?BJU International, 1999
- Age Related Urodynamic Changes in Patients with Benign Prostatic HyperplasiaJournal of Urology, 1996
- Long‐term predictive role of urodynamics: an 8‐year follow‐up of prostatic surgery for lower urinary tract symptomsBritish Journal of Urology, 1996
- A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic HyperplasiaNew England Journal of Medicine, 1995